Jefferies Group upgraded shares of Spire Healthcare Group (LON:SPI) to a buy rating in a research report released on Wednesday morning. Jefferies Group currently has GBX 290 ($3.93) price target on the stock, up from their previous price target of GBX 259 ($3.51).
A number of other analysts have also commented on SPI. Numis Securities reaffirmed an add rating and set a GBX 296 ($4.01) price objective on shares of Spire Healthcare Group in a research note on Tuesday. JPMorgan Chase & Co. reaffirmed a neutral rating and set a GBX 339 ($4.60) price objective on shares of Spire Healthcare Group in a research note on Thursday, January 4th. Liberum Capital reaffirmed a hold rating and set a GBX 270 ($3.66) price objective on shares of Spire Healthcare Group in a research note on Tuesday. Finally, Berenberg Bank reaffirmed a hold rating and set a GBX 270 ($3.66) price objective on shares of Spire Healthcare Group in a research note on Thursday, September 21st. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. The company presently has a consensus rating of Hold and an average price target of GBX 309.17 ($4.19).
Spire Healthcare Group (LON SPI) traded up GBX 3.80 ($0.05) during mid-day trading on Wednesday, reaching GBX 253.80 ($3.44). 703,989 shares of the company’s stock were exchanged, compared to its average volume of 1,280,000. Spire Healthcare Group has a 52 week low of GBX 218.20 ($2.96) and a 52 week high of GBX 362.10 ($4.91). The stock has a market capitalization of $1,020.00 and a price-to-earnings ratio of 3,625.71.
About Spire Healthcare Group
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.